Distinctive cytokine profiles in checkpoint inhibitor-induced liver injury, idiosyncratic drug-induced liver injury and autoimmune hepatitis: a potential mechanistic biomarker panel

被引：0
|
作者：
Atallah, Edmond [1 ,2 ,3 ]
Astbury, Stuart [1 ,2 ,3 ]
Grove, Jane I. [1 ,2 ,3 ]
Rao, Ankit [4 ]
Franks, Hester [4 ,5 ]
Patel, Poulam [4 ,5 ]
Aithal, Guruprasad [1 ,2 ,3 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Nottingham, England
[2] Univ Nottingham, Natl Inst Hlth Res NIHR, Nottingham Biomed Res Ctr, Nottingham, England
[3] Univ Nottingham, Sch Med, Nottingham Digest Dis Ctr, Translat Med Sci, Nottingham, England
[4] Nottingham Univ Hosp NHS Trust, Oncol, Nottingham, England
[5] Univ Nottingham, Biodiscovery Inst, Ctr Canc Sci, Translat Med Sci, Nottingham, England
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
TOP-092
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [31] Risankizumab-Associated Idiosyncratic Drug-Induced Liver Injury
    Jasti, Vivek V.
    Michaels, Anthony
    Govani, Shail
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2744 - S2744
  • [32] Diagnostic guide for immune checkpoint inhibitor-induced liver injury
    Ito, Takanori
    Takeuchi, Yasuto
    Mizuno, Kazuyuki
    Imai, Michitaka
    Yoshimaru, Yoko
    Abe, Kazumichi
    Abe, Masanori
    Matsuura, Takanori
    Yokode, Masataka
    Shiokawa, Masahiro
    Kodama, Yuzo
    Komuta, Mina
    Harada, Kenichi
    Tanaka, Atsushi
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 719 - 726
  • [33] Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis
    Weber, Sabine
    Benesic, Andreas
    Rotter, Isabelle
    Gerbes, Alexander L.
    LIVER INTERNATIONAL, 2019, 39 (10) : 1906 - 1917
  • [34] Idiosyncratic drug-induced liver injury: an update on the 2007 overview
    Hussaini, S. Hyder
    Farrington, Elizabeth Anne
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (01) : 67 - 81
  • [35] Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury
    Roth, Robert A.
    Kana, Omar
    Filipovic, David
    Ganey, Patricia E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (7-8) : 469 - 481
  • [36] In search of susceptibility factors for idiosyncratic drug-induced liver injury
    Reilly, TP
    DRUG METABOLISM REVIEWS, 2002, 34 : 44 - 44
  • [37] Autoimmune Hepatitis, Drug-induced Liver Injury or Drug-induced Autoimmune Hepatitis? Diagnostic Dilemma in a Patient With Class III Obesity
    Xie, Mengdan
    Wilson, Shanique
    Grinspan, Lauren
    Pourmand, Kamron
    Simoes, Priya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1084 - S1084
  • [38] Epidemiology and Risk Factors for Idiosyncratic Drug-Induced Liver Injury
    Bjornsson, Einar S.
    SEMINARS IN LIVER DISEASE, 2014, 34 (02) : 115 - 122
  • [39] Topiramate as the Solitary Cause of Idiosyncratic Drug-Induced Liver Injury
    Green, John
    Idriss, Rajab
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1181 - S1181
  • [40] CladribineAcute idiosyncratic drug-induced liver injury: case report
    Reactions Weekly, 2023, 1963 (1) : 166 - 166
12345